SCHEMBL16716149

SCHEMBL16716149

CNC(=O)c1[nH]c2ccc(OC)cc2c1CCN

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 1/20 0.61
HTR6 P50406 1/20 0.61
KDM4E B2RXH2 4/20 0.58
ALDH1A1 P00352 3/20 0.58
HPGD P15428 3/20 0.58
HSD17B10 Q99714 2/20 0.58
POLB P06746 1/20 0.57
MDM2 Q00987 1/20 0.57
NQO2 P16083 3/20 0.53
MTNR1A P48039 11/20 0.52
MTNR1B P49286 11/20 0.52
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 1/20 0.49
CYP2C19 P33261 1/20 0.49
AKR1C2 P52895 1/20 0.49
GAA P10253 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16711692 0.99 HTR1D (0.60) HTR1DHTR6KDM4EALDH1A1HPGD
SCHEMBL2403262 0.86 HTR1D (0.65) HTR1DHTR6KDM4EALDH1A1HPGD
SCHEMBL15427782 0.85 KDM4E (0.79) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL16711851 0.85 ALDH1A1 (0.65) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL16711699 0.85 KDM4E (0.69) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL16711952 0.84 ALDH1A1 (0.62) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL16923032 0.84 EGFR (0.52) HTR1DHTR6KDM4EALDH1A1HPGD
SCHEMBL15427985 0.84 HTR6 (0.60) HTR1DHTR6KDM4EALDH1A1HPGD
SCHEMBL18235616 0.83 TRPM8 (0.66) HTR6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL15427778 0.83 ALDH1A1 (0.63) KDM4EALDH1A1HPGDHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2873660-B1 INDOLECARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC (JP) 2016-10-26 EP disclosed
US-9376449-B2 Indole carboxamide derivative ASTELLAS PHARMA INC. (JP) 2016-06-28 US disclosed
US-20150203505-A1 INDOLE CARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2015-07-23 US disclosed
EP-2873660-A1 INDOLECARBOXAMIDE DERIVATIVE Astellas Pharma Inc. (JP) 2015-05-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203505-A1 INDOLE CARBOXAMIDE DERIVATIVE MTNR1A, MTNR1B, IDO2 HTR1D 63/4885HTR6 85/4885KDM4E 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.